Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medclair ABNGM:MCLR +1.76%71 Interest Coverage is 0 (At Loss) as of Jun. 2026. GuruFocus rates NGM:MCLR with a GF Score™ of 71/100 and a GF Value™ of kr2.21 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 463 Medical Devices & Instruments companies, Medclair AB ranks worse than 54.64% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Medclair AB's
Operating Income
for the
three
months ended in Jun. 2026 was kr-0.40 Mil. Medclair AB's Interest Expense for the
three
months ended in Jun. 2026 was kr-0.03 Mil.
did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Medclair AB's Interest Coverage or its related term are showing as below:
NGM:MCLR'
s Interest Coverage Range Over the Past 10 Years
Min: 10.54 Med: 10.54 Max: 13.29
Current: 13.29
NGM:MCLR's Interest Coverage is ranked worse than 54.64% of 463
companies
in the Medical Devices & Instruments industry
Industry Median: 16.18
vs NGM:MCLR: 13.29
Medclair AB (NGM:MCLR) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Medclair AB Interest Coverage Related Terms
Medclair AB Interest Coverage Historical Data
* Premium members only.
The historical data trend for Medclair AB's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
NGM:MCLR vs ABT, SYK, MDT: Interest Coverage Comparison
For the Medical Devices subindustry, Medclair AB's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medclair AB Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medclair AB's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Medclair AB's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Medclair AB did not have earnings to cover the interest expense.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of 0 (At Loss) mean?
Medclair AB (NGM:MCLR) has a Interest Coverage of 0 (At Loss) as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Medclair AB and its competitors. Over the past decade, Medclair AB's Interest Coverage has ranged from 10.54 to 13.29. According to the industry distribution chart, Medclair AB ranks #253 out of 463 companies in the Medical Devices & Instruments industry, placing it in the top 54.6%.
Is Medclair AB's Interest Coverage too high?
Medclair AB's current Interest Coverage is 0 (At Loss). Over the past 10 years, this metric has ranged from a low of 10.54 to a high of 13.29. Based on the distribution chart, Medclair AB ranks #253 out of 463 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Medclair AB has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medclair AB's Interest Coverage compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medclair AB ranks #253 out of 463 companies for Interest Coverage. This places Medclair AB in the lower half of its industry. The industry median Interest Coverage is 16.18. Historically, Medclair AB's own Interest Coverage has ranged from 10.54 to 13.29 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 16.18, based on 463 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Medclair AB and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 16.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medclair AB's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medclair AB stock overvalued right now?
Based on GuruFocus' analysis, Medclair AB (NGM:MCLR) is currently considered Significantly Overvalued. The stock's GF Value™ is kr2.21, compared to a current price of kr2.89 — trading 30.8% above its estimated fair value. The current Interest Coverage is 0 (At Loss). Medclair AB's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Medclair AB (NGM:MCLR), the current Interest Coverage is 0 (At Loss) as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medclair AB (NGM:MCLR) Overvalued in 2026?
Based on GuruFocus' analysis, Medclair AB stock appears to be overvalued.
The current stock price of kr2.89 is trading 30.8% above its estimated GF Value™ of kr2.21.
GuruFocus considers Medclair AB to be Significantly Overvalued.
Key valuation signals for NGM:MCLR:
Interest Coverage: 0 (At Loss)
GF Value™: kr2.21 vs. price of kr2.89 (30.8% above fair value)
No single metric tells the full story. See the NGM:MCLR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medclair AB operates in healthcare industry. The company has two units: Central Destruction Unit (CDU) and Mobile Destruction Unit (MDU) decomposes the nitrous oxide entering the unit, transforming it to nitrogen (N2) och oxygen (O2). It also provide solutions for various N2O methods such as double mask, single mask, mouthpiece, or free flow, which ensures a safe work environment for healthcare professionals.
71GF Score
Get the complete analysis for NGM:MCLR
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGM:MCLR has been successfully added to your 
